ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,641,512 | +69.4% | 5,373 | +34.3% | 0.00% | – |
Q2 2023 | $1,558,908 | +14.3% | 4,000 | +9.3% | 0.00% | – |
Q1 2023 | $1,363,911 | -2.9% | 3,661 | -1.2% | 0.00% | – |
Q4 2022 | $1,404,132 | -11.0% | 3,707 | -17.1% | 0.00% | – |
Q3 2022 | $1,577,000 | -25.6% | 4,470 | -20.1% | 0.00% | – |
Q2 2022 | $2,119,000 | +4.2% | 5,594 | -13.2% | 0.00% | – |
Q1 2022 | $2,033,000 | -6.1% | 6,447 | +4.4% | 0.00% | – |
Q4 2021 | $2,164,000 | +69.5% | 6,176 | +46.0% | 0.00% | – |
Q3 2021 | $1,277,000 | +9.2% | 4,229 | +8.9% | 0.00% | – |
Q2 2021 | $1,169,000 | -0.5% | 3,884 | -9.0% | 0.00% | – |
Q1 2021 | $1,175,000 | -29.1% | 4,269 | -24.3% | 0.00% | – |
Q4 2020 | $1,658,000 | +8.3% | 5,637 | -3.3% | 0.00% | – |
Q3 2020 | $1,531,000 | -4.0% | 5,830 | -17.6% | 0.00% | – |
Q2 2020 | $1,594,000 | +72.0% | 7,075 | +0.5% | 0.00% | – |
Q1 2020 | $927,000 | -26.6% | 7,038 | -10.5% | 0.00% | – |
Q4 2019 | $1,263,000 | +91.9% | 7,868 | +36.3% | 0.00% | – |
Q3 2019 | $658,000 | -35.2% | 5,772 | -19.6% | 0.00% | – |
Q2 2019 | $1,016,000 | +10.4% | 7,179 | -2.6% | 0.00% | – |
Q1 2019 | $920,000 | +62.0% | 7,367 | +24.6% | 0.00% | – |
Q4 2018 | $568,000 | -30.8% | 5,912 | -45.4% | 0.00% | – |
Q3 2018 | $821,000 | -7.4% | 10,831 | +1.1% | 0.00% | – |
Q2 2018 | $887,000 | +6.1% | 10,709 | +3.0% | 0.00% | – |
Q1 2018 | $836,000 | -7.9% | 10,397 | -27.7% | 0.00% | – |
Q4 2017 | $908,000 | – | 14,378 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |